CSIMarket
 
Milestone Scientific Inc   (NYSEAMER: MLSS)
 
Price: $0.4718 $0.01 2.565%
Day's High: $0.48500001430511475 Week Perf: -5.64 %
Day's Low: $ 0.45 30 Day Perf: 0.38 %
Volume (M): 30,282 52 Wk High: $ 0.64
Volume (M$): $ 0 52 Wk Avg: $0.37
Open: $0.45 52 Wk Low: $0.22



 Market Capitalization (Millions $) 44
 Shares Outstanding (Millions) 93
 Employees 15
 Revenues (TTM) (Millions $) 9
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Milestone Scientific Inc is a medical technology company that focuses on developing and marketing innovative and advanced injection technologies. The company's flagship product is the CompuFlo Epidural System, which provides a computer-controlled method for administering epidural anesthesia and other drugs. Milestone Scientific Inc also offers other specialty injection products, such as those for dental applications. The company's technologies aim to improve patient comfort, reduce pain and complications, and enhance the efficiency of medical procedures. Milestone Scientific Inc operates globally, catering to healthcare professionals and institutions worldwide.


   Company Address: 425 Eagle Rock Avenue Roseland 7068 NJ
   Company Phone Number: 535-2717   Stock Exchange / Ticker: NYSEAMER MLSS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GTHP        6.38% 
ISRG        0.43% 
MMM   -6.76%    
OSUR   -3.39%    
SYK   -3.8%    
WST   -1.61%    
• View Complete Report
   



Contract

Milestone Scientific Secures FSS Approval for CompuFlo Epidural System, Expanding Reach in Federal Healthcare Markets

Published Tue, Nov 26 2024 1:30 PM UTC

Milestone Scientific Inc. (NYSE: MLSS) has recently announced that it has secured approval for the Federal Supply Schedule (FSS) on its CompuFlo Epidural System. This significant milestone is expected to unlock new market opportunities across various federal healthcare systems, enhancing the availability of this innovative technology to healthcare providers and patients alik...

Management Changes

Milestone Scientific Navigates New Horizons: Leadership Transition Coincides with Groundbreaking Innovations in Pain Management,

Published Thu, Nov 14 2024 9:00 PM UTC

Milestone Scientific Inc. a leading player in the field of computerized drug delivery instruments, has announced a significant leadership transition that marks the end of an era as CEO Arjan Haverhals prepares for retirement. Effective December 31, 2024, Haverhals will step down from his role as chief executive officer but will continue to serve the company as a board direct...

Product Service News

Revolutionizing Pain Management Milestone Scientifics CompuFlo Epidural System Launches at iHeal, Backed ...

Published Thu, Oct 3 2024 3:00 PM UTC

Milestone Scientific Inc. recently announced an exciting development in the medical field with the commercial rollout of its advanced CompuFlo Epidural System at iHeal Pain Center. This groundbreaking system promises to revolutionize how epidural analgesia is administered, enhancing the safety and efficacy of pain management treatments. The decision to introduce the CompuFlo...

Partnership

Milestone Scientific and Axial Biologics Forge Partnership to Distribute Cutting-Edge Epidural System in Key St...

Published Wed, Aug 7 2024 2:00 PM UTC

By CSIMarket.com Staff WriterIn a significant move poised to transform epidural procedures, Milestone Scientific Inc. (NYSE: MLSS) announced a strategic alliance with Axial Biologics to distribute its pioneering CompuFlo Epidural System in New Jersey, Texas, and Florida. This collaboration, revealed on August 7, 2024, underlines the ongoing efforts to enhance medical tech...

Product Service News

Milestone Scientific Makes Strides in Pain-Free Drug Delivery, Securing Medicare Approval and Dental Market Expansion...

Published Tue, Jul 23 2024 12:30 PM UTC

Milestone Scientific Expands Market Presence with Medicare Price Assignment and Direct Sales InitiativesMilestone Scientific, a leading developer of computerized drug delivery instruments specializing in painless and precise injections, announced two significant developments that are set to bolster its market presence and drive growth. The company has secured a Medicare Part...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.96
Price to Sales (Expected) -
Price to Book 12.66
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.49
Working Capital Ratio 1.06
Leverage Ratio (MRQ) 2.57
Total Debt to Equity 0.13
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.04 $
Revenues (TTM) 0.1 $
Cash Flow (TTM) -
Cash 0.04 $
Book Value 0.04 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 590,317
Net Income per Employee (TTM) -276,247
Receivable Turnover Ratio (TTM) 11.98
Inventory Turnover Ratio (TTM) 0.77
Asset Turnover Ratio (TTM) 1.05

Profitability Ratios Current
Gross Margin (MRQ) 67.23 %
Operating Margin (MRQ) -37.37 %
Net Margin (MRQ) -37.29 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Milestone Scientific Inc's Segments
Medical    7.53 % of total Revenue
Dental    168.57 % of total Revenue
Grand Total    176.1 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.